Back to Search
Start Over
Comment re: continuous rather than intermittent administration of fenretinide in leukoplakia.
- Source :
-
Cancer prevention research (Philadelphia, Pa.) [Cancer Prev Res (Phila)] 2009 Mar; Vol. 2 (3), pp. 281; author reply 281. Date of Electronic Publication: 2009 Mar 03. - Publication Year :
- 2009
- Subjects :
- Anticarcinogenic Agents adverse effects
Cell Line, Tumor
Cell Proliferation drug effects
Clinical Trials as Topic
Dose-Response Relationship, Drug
Fenretinide adverse effects
Humans
Research Design
Time Factors
Treatment Outcome
Anticarcinogenic Agents administration & dosage
Fenretinide administration & dosage
Leukoplakia, Oral drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1940-6215
- Volume :
- 2
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Cancer prevention research (Philadelphia, Pa.)
- Publication Type :
- Editorial & Opinion
- Accession number :
- 19258538
- Full Text :
- https://doi.org/10.1158/1940-6207.CAPR-09-0011